Citius Oncology closes $9.0M public offering of 6.82M shares & warrants

CITIUS ONCOLOGY, INC.

Priced 6,818,182 units at $1.32 each, each consisting of 1 share + 1 warrant for 1 common share.
Gross proceeds ~$9.0M; net proceeds ~$7.44M after placement agent fees and expenses.
Warrants exercisable at $1.32/share, immediately exercisable, expire 5 years from issuance.
Proceeds to support LYMPHIR commercialization, milestone/royalty payments, and working capital.
Placement agent Maxim Group LLC; 45-day lock-up on new share issuance after closing.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.